NFE2L2 and metabolic dysfunction-associated steatohepatitis: <p>Mitochondrial- and NOX4-derived ROS drive NFE2L2 antioxidant defense to attenuate the progression to non-alcoholic steatohepatitis and fibrosis in obesity.</p>